Sevilla, Daniel Alfonso Cisneros
Hofman, Denise
Madero, Sergio Díaz
Fernández, Miriam Contreras
Kudla, Urszula
Kontopodi, Eva
Hageman, Jeske H. J.
Ángel, Darelia Alelí Topete
Esquer, Joshué David Covarrubias
Funding for this research was provided by:
FrieslandCampina
Article History
Received: 1 April 2022
Accepted: 31 October 2022
First Online: 22 November 2022
Declarations
:
: The study protocol, information letter to parents/legal guardians and written informed consent forms were approved by the ethical committee of Clínica de Enfermedades Crónicas y de Procedimientos Especiales S.C; (Michocan, Mexico) (record number: 001_2019). Upon completion of the study, parents received a €50 voucher as well as 4 complementary tins of study products as a compensation for their time. The study was conducted in accordance with the guidelines of the Declaration of Helsinki and the International Conference on Harmonization (ICH) guidelines on Good Clinical Practice (GCP) and was registered in the Netherlands Trial Registry [identifier: NL7420 (NTR7653)], registration date 20/09/2018.
: Not applicable.
: Denise Hofman, Miriam Contreras, Urszula Kudla, Eva Kontopodi, and Jeske Hageman are employees of FrieslandCampina at the time of manuscript creation. Daniel Alfonso Cisneros Sevilla, Darelia Alelí Topete Ángel, Sergio Díaz Madero, and Joshué David Covarrubias Esquer report no conflicts of interest.